DataSheet_1_Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children.docx

Background As SARS-CoV-2 will likely continue to circulate, low-impact methods become more relevant to monitor antibody-mediated immunity. Saliva sampling could provide a non-invasive method with reduced impact on children. Studies reporting on the differences between systemic and mucosal humoral immunity to SARS-CoV-2 are inconsistent in adults and scarce in children. These differences may be further unraveled by exploring associations to demographic and clinical variables. Methods To evaluate the use of saliva antibody assays, we performed a cross-sectional cohort study by collecting serum a... Mehr ...

Verfasser: Maya W. Keuning
Marloes Grobben
Merijn W. Bijlsma
Beau Anker
Eveline P. Berman-de Jong
Sophie Cohen
Mariet Felderhof
Anne-Elise de Groen
Femke de Groof
Maarten Rijpert
Hetty W. M. van Eijk
Khadija Tejjani
Jacqueline van Rijswijk
Maurice Steenhuis
Theo Rispens
Frans B. Plötz
Marit J. van Gils
Dasja Pajkrt
Dokumenttyp: Dataset
Erscheinungsdatum: 2022
Schlagwörter: Immunology / Applied Immunology (incl. Antibody Engineering / Xenotransplantation and T-cell Therapies) / Autoimmunity / Cellular Immunology / Humoural Immunology and Immunochemistry / Immunogenetics (incl. Genetic Immunology) / Innate Immunity / Transplantation Immunology / Tumour Immunology / Immunology not elsewhere classified / Genetic Immunology / Animal Immunology / Veterinary Immunology / SARS-CoV-2 / mucosal antibody response / mucosal IgG / antibody prevalence / children / saliva antibodies
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-26631520
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3389/fimmu.2022.976382.s001